litlas
Log inCreate account

Fabrizio Pane

Active 1979–2025

120
Papers
18,614
Citations
64
h-index
111
i10-index

Citations

Citations per year for Fabrizio Pane1979: 9 citations1996: 3 citations1997: 5 citations1998: 2 citations1999: 17 citations2000: 8 citations2001: 16 citations2002: 24 citations2003: 28 citations2004: 31 citations2005: 32 citations2006: 43 citations2007: 64 citations2008: 60 citations2009: 103 citations2010: 107 citations2011: 126 citations2012: 119 citations2013: 115 citations2014: 117 citations2015: 159 citations2016: 145 citations2017: 112 citations2018: 98 citations2019: 392 citations2020: 494 citations2021: 534 citations2022: 387 citations2023: 256 citations2024: 481 citations2025: 171 citations2026: 3 citations1980–1995: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,196 citing papers, 18.8% of this breakdownItaly: 723 citing papers, 11.4% of this breakdownGermany: 524 citing papers, 8.3% of this breakdownUnited Kingdom: 459 citing papers, 7.2% of this breakdownFrance: 396 citing papers, 6.2% of this breakdownChina: 243 citing papers, 3.8% of this breakdownSpain: 223 citing papers, 3.5% of this breakdownNetherlands: 189 citing papers, 3% of this breakdownAustralia: 182 citing papers, 2.9% of this breakdownSwitzerland: 180 citing papers, 2.8% of this breakdownCanada: 162 citing papers, 2.6% of this breakdownJapan: 130 citing papers, 2.1% of this breakdown
0%18.8%Other 27.4%

Institutions

Fields

  • Medicine85.4%
  • Biochemistry, Genetics and Molecular Biology8.8%
  • Immunology and Microbiology3.7%
  • Computer Science0.6%
  • Neuroscience0.3%
  • Chemistry0.2%
  • Other1%

Topics

  • Chronic Myeloid Leukemia Treatments14.7%
  • Acute Myeloid Leukemia Research8.9%
  • Chronic Lymphocytic Leukemia Research7.5%
  • Eosinophilic Disorders and Syndromes7.5%
  • Acute Lymphoblastic Leukemia research5.8%
  • Myeloproliferative Neoplasms: Diagnosis and Treatment5.6%
  • Other50%

Coauthors

All papers

Open in search
  1. European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia

    Authors: Andreas Hochhaus, Michele Baccarani, Richard T. Silver, CA Schiffer, Jane F. Apperley, Francisco Cervantes, R E Clark, J. E. Cortes, Michael W. Deininger, François Guilhot, Henrik Hjorth‐Hansen, Timothy P. Hughes, J. Janssen, Hagop M. Kantarjian, D. W. Kim, Richard A. Larson, J. H. Lipton, F.-X. Mahon, Jiří Mayer, Franck E. Nicolini, D Niederwieser, Fabrizio Pane, Jerald P. Radich, Delphine Réa, Johan Richter, G Rosti, Philipe Rousselot, Giuseppe Saglio, Susanne Saußele, Simona Soverini, J. L. Steegmann, Anna Turkina, Andrey Zaritskey, R. Hehlmann - Leukemia 2020 cited by 1,510

  2. Ruxolitinib versus Standard Therapy for the Treatment of Polycythemia Vera

    Authors: Alessandro M. Vannucchi, Jean‐Jacques Kiladjian, Martin Grießhammer, Tamás Masszi, Simon Durrant, Francesco Passamonti, Claire Harrison, Fabrizio Pane, Pierre Zachée, Ruben A. Mesa, Shui He, Mark M. Jones, William M. Garrett, Jingjin Li, Ulrich Pirron, Dany Habr, Srđan Verstovšek - New England Journal of Medicine 2015 cited by 872

  3. European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013

    Authors: Michele Baccarani, Michael Deininger, Gianantonio Rosti, Andreas Hochhaus, Simona Soverini, Jane F. Apperley, Francisco Cervantes, Richard E. Clark, Jörge E. Cortes, François Guilhot, Henrik Hjorth‐Hansen, Timothy P. Hughes, Hagop M. Kantarjian, Dong‐Wook Kim, Richard A. Larson, Jeffrey H. Lipton, François-Xavier Mahon, Giovanni Martinelli, Jiřı́ Mayer, Martin Müller, Dietger Niederwieser, Fabrizio Pane, Jerald P. Radich, Philippe Rousselot, Giuseppe Saglio, Susanne Saußele, Charles A. Schiffer, Richard T. Silver, Bengt Simonsson, Juan-Luis Steegmann, John M. Goldman, Rüdiger Hehlmann - Blood 2013 cited by 1,989

  4. Standardization and quality control studies of ‘real-time’ quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia – A Europe Against Cancer Program

    Authors: J Gäbert, Emmanuel Beillard, Vincent H. J. van der Velden, W Bi, David Grimwade, Niels Pallisgaard, Gisela Barbany, Giovanni Cazzaniga, J M Cayuela, Hélène Cavé, Fabrizio Pane, Joeri L. Aerts, Daniela De Micheli, Xavier Thirion, Vincent Pradel, Marcos González, Susanne Viehmann, M Malec, Giuseppe Saglio, Jacques J. M. van Dongen - Leukemia 2003 cited by 1,528

  5. Diagnostic capabilities, clinical features, and longitudinal UBA1 clonal dynamics of a nationwide VEXAS cohort

    Authors: Carmelo Gurnari, Maria Rosaria Pascale, Antonio Vitale, Elisa Diral, Alessandro Tomelleri, Elisa Galossi, Giulia Falconi, Alessandro Bruno, Francesca Crisafulli, Micol Frassi, Chiara Cattaneo, Diego Bertoli, Massimo Bernardi, Annalisa Condorelli, Erika Morsia, Antonella Poloni, Elena Crisà, Daniela Caravelli, Paola Triggianese, Luisa Brussino, Giorgia Battipaglia, Sara Bindoli, Paolo Sfriso, Federico Caroni, Matteo Dragani, Flavia Mallegni, Federica Pilo, Davide Firinu, Antonio Curti, Cristina Papayannidis, Attilio Olivieri, Shahram Kordasti, Francesco Albano, Fabrizio Pane, Pellegrino Musto, Monica Bocchia, Elisabetta Lugli, Massimo Breccia, Marco Frigeni, Lorenzo Dagna, Raffaella Greco, Franco Franceschini, Corrado Campochiaro, Luca Cantarini, Maria Teresa Voso - American Journal of Hematology 2023 cited by 44

  6. Consensus-based definition of unfitness to intensive and non-intensive chemotherapy in acute myeloid leukemia: a project of SIE, SIES and GITMO group on a new tool for therapy decision making

    Authors: Felicetto Ferrara, Giovanni Barosi, Adriano Venditti, Emanuele Angelucci, Marco Gobbi, Fabrizio Pane, Patrizia Tosi, Pier Luigi Zinzani, S Tura - Leukemia 2013 cited by 169

  7. Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study

    Authors: Francesco Passamonti, Chiara Cattaneo, Luca Arcaini, Riccardo Bruna, Michèle Cavo, Francesco Merli, Emanuele Angelucci, Mauro Krampera, Roberto Cairoli, Matteo Giovanni Della Porta, Nicola Stefano Fracchiolla, Marco Ladetto, Carlo Gambacorti‐Passerini, Marco Salvini, Monia Marchetti, Roberto M. Lemoli, Alfredo Molteni, Alessandro Busca, Antonio Cuneo, Alessandra Romano, Nicola Giuliani, Sara Galimberti, Alessandro Corso, Alessandro Morotti, Brunangelo Falini, Atto Billio, Filíppo Gherlinzoni, Giuseppe Visani, Maria Chiara Tisi, Agostino Tafuri, Patrizia Tosi, Francesco Lanza, Massimo Massaia, Mauro Turrini, Felicetto Ferrara, Carmela Gurrieri, Daniele Vallisa, Maurizio Martelli, Enrico Derenzini, Attilio Guarini, Annarita Conconi, Annarosa Cuccaro, Laura Cudillo, Domenico Russo, Fabrizio Ciambelli, Anna Maria Scattolin, Mario Luppi, Carmine Selleri, Elettra Ortu La Barbera, Celestino Ferrandina, Nicola Di Renzo, Attilio Olivieri, Monica Bocchia, Massimo Gentile, Francesco Marchesi, Pellegrino Musto, Augusto B. Federici, Anna Candoni, Adriano Venditti, Carmen Fava, Antonio Pinto, Piero Galieni, Luigi Rigacci, Daniele Armiento, Fabrizio Pane, Margherita Oberti, Patrizia Zappasodi, Carlo Visco, Matteo Franchi, Paolo Grossi, Lorenza Bertù, Giovanni Corrao, Livio Pagano, Paolo Corradini - The Lancet Haematology 2020 cited by 554

  8. Ropeginterferon versus Standard Therapy for Low-Risk Patients with Polycythemia Vera

    Authors: Tiziano Barbui, Alessandro M. Vannucchi, Valerio De Stefano, Alessandra Carobbio, Arianna Ghirardi, Greta Carioli, Arianna Masciulli, Elena Rossi, Fabio Ciceri, Massimiliano Bonifacio, Alessandra Iurlo, Francesca Palandri, Giulia Benevolo, Fabrizio Pane, Alessandra Ricco, Giuseppe Carli, Marianna Caramella, Davide Rapezzi, Caterina Musolino, Sergio Siragusa, Elisa Rumi, Andrea Patriarca, Nicola Cascavilla, Barbara Mora, Emma Cacciola, Carmela Mannarelli, Giuseppe Gaetano Loscocco, Paola Guglielmelli, Francesca Gesullo, Silvia Betti, Francesca Lunghi, Luigi Scaffidi, Cristina Bucelli, Nicola Vianelli, Marta Bellini, Maria Chiara Finazzi, Gianni Tognoni, Alessandro Rambaldi - NEJM Evidence 2023 cited by 51

  9. IKZF1 (Ikaros) Deletions in BCR-ABL1 –Positive Acute Lymphoblastic Leukemia Are Associated With Short Disease-Free Survival and High Rate of Cumulative Incidence of Relapse: A GIMEMA AL WP Report

    Authors: Giovanni Martinelli, Ilaria Iacobucci, Clelia Tiziana Storlazzi, Marco Vignetti, Francesca Paoloni, Daniela Cilloni, Simona Soverini, Antonella Vitale, Sabina Chiaretti, Giuseppe Cimino, Cristina Papayannidis, Stefania Paolini, Loredana Elia, Paola Fazi, Giovanna Meloni, Sergio Amadori, Giuseppe Saglio, Fabrizio Pane, Michele Baccarani, Robin Foà - Journal of Clinical Oncology 2009 cited by 322

  10. Ropeginterferon alfa-2b versus phlebotomy in low-risk patients with polycythaemia vera (Low-PV study): a multicentre, randomised phase 2 trial

    Authors: Tiziano Barbui, Alessandro M. Vannucchi, Valerio De Stefano, Arianna Masciulli, Alessandra Carobbio, Alberto Ferrari, Arianna Ghirardi, Elena Rossi, Fabio Ciceri, Massimiliano Bonifacio, Alessandra Iurlo, Francesca Palandri, Giulia Benevolo, Fabrizio Pane, Alessandra Ricco, Giuseppe Carli, Marianna Caramella, Davide Rapezzi, Caterina Musolino, Sergio Siragusa, Elisa Rumi, Andrea Patriarca, Nicola Cascavilla, Barbara Mora, Emma Cacciola, Carmela Mannarelli, Giuseppe Gaetano Loscocco, Paola Guglielmelli, Silvia Betti, Francesca Lunghi, Luigi Scaffidi, Cristina Bucelli, Nicola Vianelli, Marta Bellini, Maria Chiara Finazzi, Gianni Tognoni, Alessandro Rambaldi - The Lancet Haematology 2021 cited by 132

  11. Chronic Myeloid Leukemia: An Update of Concepts and Management Recommendations of European LeukemiaNet

    Authors: Michele Baccarani, Jörge E. Cortes, Fabrizio Pane, Dietger Niederwieser, Giuseppe Saglio, Jane F. Apperley, Francisco Cervantes, Michael W. Deininger, Aloïs Gratwohl, François Guilhot, Andreas Hochhaus, Mary M. Horowitz, Timothy P. Hughes, Hagop M. Kantarjian, Richard A. Larson, Jerald P. Radich, Bengt Simonsson, Richard T. Silver, John M. Goldman, Rüdiger Hehlmann - Journal of Clinical Oncology 2009 cited by 1,298

  12. Cardiovascular Toxicities of Immune Therapies for Cancer – A Scientific Statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio-Oncology

    Authors: Carlo G. Tocchetti, Dimitrios Farmakis, Yvonne Koop, María Sol Andrés, Liam S. Couch, Luigi Formisano, Fortunato Ciardiello, Fabrizio Pane, Lewis Au, Max Emmerich, Chris Plummer, Geeta Gulati, Sivatharshini Ramalingam, Daniela Cardinale, Christine Brezden‐Masley, Zaza Iakobishvili, Paaladinesh Thavendiranathan, Ciro Santoro, Jutta Bergler‐Klein, Kalliopi Keramida, Rudolf A. de Boer, Christoph Maack, Esther Lutgens, Tienush Rassaf, Michael G. Fradley, Javid J. Moslehi, Eric H. Yang, Gilles W. De Keulenaer, Pietro Ameri, Jeroen J. Bax, Tomas G. Neilan, Joerg Herrmann, Amam Mbakwem, Mariana Mirabel, Hadi Skouri, Emilio Hirsch, Alain Cohen‐Solal, Aaron L. Sverdlov, Peter van der Meer, Riccardo Asteggiano, Ana Barac, Bonnie Ky, Daniel J. Lenihan, Susan Dent, Petar Seferović, Andrew J.S. Coats, Marco Metra, Giuseppe Rosano, Thomas Suter, Teresa López‐Fernández, Alexander R. Lyon - European Journal of Heart Failure 2024 cited by 68

  13. Ruxolitinib in cytopenic myelofibrosis: Response, toxicity, drug discontinuation, and outcome

    Authors: Francesca Palandri, Massimo Breccia, Camilla Mazzoni, Giuseppe Auteri, Elena Maria Elli, Malgorzata Monika Trawinska, Nicola Polverelli, Mario Tiribelli, Giulia Benevolo, Alessandra Iurlo, Alessia Tieghi, Florian H. Heidel, Giovanni Caocci, Eloise Beggiato, Gianni Binotto, Francesco Cavazzini, Maurizio Miglino, Costanza Bosi, Monica Crugnola, Monica Bocchia, Bruno Martino, Novella Pugliese, Mattia Biondo, Marta Venturi, Luigi Scaffidi, Alessandro Isidori, Daniele Cattaneo, Mauro Krampera, Fabrizio Pane, Daniela Cilloni, Gianpietro Semenzato, Roberto M. Lemoli, Antonio Cuneo, Elisabetta Abruzzese, Daniela Bartoletti, Simona Paglia, Nicola Vianelli, Michèle Cavo, Massimiliano Bonifacio, Giuseppe A. Palumbo - Cancer 2023 cited by 40

  14. Dasatinib discontinuation in patients with chronic-phase chronic myeloid leukemia and stable deep molecular response: the DASFREE study

    Authors: Neil P. Shah, Valentín García‐Gutiérrez, Antonio Jiménez‐Velasco, Sarah M. Larson, Susanne Saußele, Delphine Réa, François‐Xavier Mahon, Moshe Levy, María Teresa Gómez‐Casares, Fabrizio Pane, Franck‐Emmanuel Nicolini, Michael J. Mauro, Oumar Sy, Patricia Martin‐Regueira, Jeffrey H. Lipton - Leukemia & lymphoma/Leukemia and lymphoma 2019 cited by 150

  15. Ruxolitinib discontinuation syndrome: incidence, risk factors, and management in 251 patients with myelofibrosis

    Authors: Francesca Palandri, Giuseppe A. Palumbo, Elena Maria Elli, Nicola Polverelli, Giulia Benevolo, Bruno Martino, Elisabetta Abruzzese, Mario Tiribelli, Alessia Tieghi, Roberto Latagliata, Francesco Cavazzini, Micaela Bergamaschi, Gianni Binotto, Monica Crugnola, Alessandro Isidori, Giovanni Caocci, Florian H. Heidel, Novella Pugliese, Costanza Bosi, Daniela Bartoletti, Giuseppe Auteri, Daniele Cattaneo, Luigi Scaffidi, Malgorzata Monica Trawinska, Rossella Stella, F Ciantia, Fabrizio Pane, Antonio Cuneo, Mauro Krampera, Gianpietro Semenzato, Roberto M. Lemoli, Alessandra Iurlo, Nicola Vianelli, Michèle Cavo, Massimo Breccia, Massimiliano Bonifacio - Blood Cancer Journal 2021 cited by 75

  16. Sequential Chemotherapy and Blinatumomab to Improve Minimal Residual Disease in Adult Ph- B-Lineage Acute Lymphoblastic Leukemia. Final Results of the Phase II Gimema LAL2317 Trial

    Authors: Sabina Chiaretti, Irene Della Starza, Alessandra Santoro, Orietta Spinelli, Loredana Elia, Maria Stefania De Propris, Matteo Piccini, Patrizia Chiusolo, Felicetto Ferrara, Patrizia Zappasodi, Erika Borlenghi, Catello Califano, Monica Bocchia, Elisa Mauro, Fabrizio Pane, Anna Candoni, Albana Liço, Ernesta Audisio, Monia Lunghi, Anna Maria Mianulli, Mariangela Di Trani, Valentina Arena, Monica Messina, Alfonso Piciocchi, Paola Fazi, Alessandro Rambaldi, Robin Foà, Renato Bassan - Blood 2023 cited by 27

  17. New scenarios in Vacuoles, E1 enzyme, X linked, Autoinflammatory, Somatic (VEXAS) syndrome: Evolution from myelodysplastic syndrome to acute myeloid leukemia

    Authors: Giorgia Battipaglia, Annamaria Vincenzi, Giulia Falconi, Alessia Fiore, Francesco D’Agostino, Raffaella Iannotta, Francesco Grimaldi, Carmelo Gurnari, Elisa Galossi, Elena Crisà, Francesca Bonello, Giulia Scalia, Barbara Izzo, Maria Teresa Voso, Fabrizio Pane - Current Research in Translational Medicine 2023 cited by 23

  18. BCR-ABL kinase domain mutation analysis in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: recommendations from an expert panel on behalf of European LeukemiaNet

    Authors: Simona Soverini, Andreas Hochhaus, Franck E. Nicolini, Franz Gruber, Thoralf Lange, Giuseppe Saglio, Fabrizio Pane, Martin C. Müller, Thomas Ernst, Gianantonio Rosti, Kimmo Porkka, Michele Baccarani, Nicholas C.P. Cross, Giovanni Martinelli - Blood 2011 cited by 579

  19. Lessons for the clinic from rituximab pharmacokinetics and pharmacodynamics

    Authors: Josée Golay, Gianpietro Semenzato, Alessandro Rambaldi, Robin Foà, Gianluca Gaïdano, Enrica Gamba, Fabrizio Pane, Antonello Pinto, Giorgina Specchia, Francesco Zaja, Mario Regazzi - mAbs 2013 cited by 154

  20. Long-term efficacy and safety of ruxolitinib versus best available therapy in polycythaemia vera (RESPONSE): 5-year follow up of a phase 3 study

    Authors: Jean‐Jacques Kiladjian, Pierre Zachée, Masayuki Hino, Fabrizio Pane, Tamás Masszi, Claire Harrison, Ruben A. Mesa, Carole B. Miller, Francesco Passamonti, Simon Durrant, Martin Grießhammer, Keita Kirito, Carlos Besses, Beatriz Moiraghi, Elisa Rumi, Vittorio Rosti, Igor Wolfgang Blau, Nathalie Francillard, Tuochuan Dong, Monika Wroclawska, Alessandro M. Vannucchi, Srđan Verstovšek - The Lancet Haematology 2020 cited by 142

  21. Laboratory recommendations for scoring deep molecular responses following treatment for chronic myeloid leukemia

    Authors: Nicholas C.P. Cross, Helen White, Dolors Colomer, Hans Ehrencrona, Letizia Foroni, Enrico Gottardi, Thoralf Lange, Thomas Lion, Kateřina Machová Poláková, Stéphanie Dulucq, Giovanni Martinelli, Elisabeth Oppliger Leibundgut, Niels Pallisgaard, Gisela Barbany, Tomasz Sacha, Rodica Tălmaci, Barbara Izzo, Giuseppe Saglio, Fabrizio Pane, Martin C. Müller, Andreas Hochhaus - Leukemia 2015 cited by 342

  22. Metabolic Tumor Volume Assessed by 18F-FDG PET/CT for the Prediction of Outcome in Patients with Multiple Myeloma

    Authors: Rosa Fonti, Michele Larobina, Silvana Del Vecchio, Serena De Luca, Rossella Fabbricini, Lucio Catalano, Fabrizio Pane, Marco Salvatore, Leonardo Pace - Journal of Nuclear Medicine 2012 cited by 185

  23. Prospective assessment of NGS-detectable mutations in CML patients with nonoptimal response: the NEXT-in-CML study

    Authors: Simona Soverini, Luana Bavaro, Caterina De Benedittis, Margherita Martelli, Alessandra Iurlo, Nicola Orofino, Simona Sica, Federica Sorà, Francesca Lunghi, Fabio Ciceri, Sara Galimberti, Claudia Baratè, Massimiliano Bonifacio, Luigi Scaffidi, Fausto Castagnetti, Gabriele Gugliotta, Francesco Albano, Antonella Vita Russo Rossi, Fabio Stagno, Francesco Di Raimondo, Mariella D’Adda, Eros Di Bona, Elisabetta Abruzzese, Gianni Binotto, Rosaria Sancetta, Marzia Salvucci, Isabella Capodanno, Mariella Girasoli, Sabrina Coluzzi, Immacolata Attolico, Caterina Musolino, Elisabetta Calistri, Mario Annunziata, Monica Bocchia, Stefania Stella, Anna Serra, Santa Errichiello, Giuseppe Saglio, Fabrizio Pane, Paolo Vigneri, Flavio Mignone, Maria Antonella Laginestra, Stefano Pileri, Antonio Percesepe, Elena Tenti, Gianantonio Rosti, Michele Baccarani, Michèle Cavo, Giovanni Martinelli - Blood 2019 cited by 99

  24. Observational study of chronic myeloid leukemia Italian patients who discontinued tyrosine kinase inhibitors in clinical practice

    Authors: Carmen Fava, Giovanna Rege‐Cambrin, Irene Dogliotti, Marco Cerrano, Paola Berchialla, Matteo Dragani, Gianantonio Rosti, Fausto Castagnetti, Gabriele Gugliotta, Bruno Martino, Carlo Gambacorti‐Passerini, Elisabetta Abruzzese, Chiara Elena, Patrizia Pregno, Antonella Gozzini, Isabella Capodanno, Micaela Bergamaschi, Monica Crugnola, Monica Bocchia, Sara Galimberti, Davide Rapezzi, Alessandra Iurlo, Daniele Cattaneo, Roberto Latagliata, Massimo Breccia, Michele Cedrone, Marco Santoro, Mario Annunziata, Luciano Levato, Fabio Stagno, Francesco Cavazzini, Nicola Sgherza, Valentina Giai, Luigia Luciano, Sabina Russo, Pellegrino Musto, Giovanni Caocci, Federica Sorà, Francesco Iuliano, Francesca Lunghi, Giorgina Specchia, Fabrizio Pane, Dario Ferrero, Michele Baccarani, Giuseppe Saglio - Haematologica 2019 cited by 77